Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin. Founded in 2010, headquartered in Singapore, Singapore. The company has raised $25.7M in funding at the series c stage. The team comprises 47 (Jun 30, 2026) employees. Backed by investors including ZIG Ventures, Clavystbio. Biobot Surgical operates in the Surgical Instruments, Professional Service Robots sectors. The company focuses on Surgery, Robotic Surgery. The company has a team of 47 employees. The company is categorized under Life Sciences > Surgical Instruments; High Tech > Professional Service Robots.
← All startups
Biobot Surgical
Series CDeveloper of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin. Founded in 2010, headquartered in Singapore, Singapore. The company has raised $25.7M in funding at the series c stage. The team comprises 47 (Jun…
About
Business model
Professional Service Robots > Healthcare > Surgery,
Surgical Instruments > Robotic Surgery
Institutional investors
ZIG VenturesClavystbioTony TanWai Hoong TangYew Bock TanAw May LingLennard Harold Thean See YinJoseph Lee
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.